The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr comes as the U.S. records its first ...

Novavax (NASDAQ: NVAX) signed a deal worth at least $1.2 billion with French drugmaker Sanofi (EPA: SASY) in May to hand over ...